Trebananib Completed Phase 1 Trials for Gynecological Malignancies / Malignancies / Tumors, Solid / Carcinoma NOS / Metastases / Cancer of the Ovary / Tumors / Fallopian Tube Cancer / Oncology Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00102830Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
NCT00770536AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR